Candel Therapeutics, a biopharmaceutical company developing novel oncolytic viral immunotherapies, filed for an IPO July 26. It began trading under “CADL” on July 27. Based in Needham, Mass., Candel aims to improve cancer survival while maintaining quality of life.
Together, the minds behind Candel have:
Let’s take a look at the patents, publications, clinical trials, and grants of the people behind Candel. The minds behind Candel:
Dr. Paul Peter Tak
The president and CEO of the company has published 574 peer-reviewed publications, several book chapters, and books. He also has 13 patents and has led over 25 clinical trials.
This network graph indicates the research areas and categories of his patents as well as their connections.
Dr. Tak's patent research areas and categories and how they are related
Many of his publications involve fascia. See this Sankey diagram below for more details.
Dr. Tak's publications by research areas and categories
Dr. Estuardo Aguilar-Cordova
The founder and Chief Scientific Officer has 12 patents, 25 publications, and 6 grants
This Sankey diagram shows Dr. Aguilar-Cordova's patents by status (grant versus application).
Dr. Aguilar-Cordova's patents by status
As this bar chart shows, most of his publications have been on valaciclovir, an antiviral medication.
Dr. Aguilar-Cordova's publications by research area over time
This Sankey diagram shows his grants by research area and category.
Dr. Aguilar-Cordova's grants by research area and category
Dr. Francesca Barone
The Vice President and Head of Research has 97 publications and 2 grants.
Most of her publications have been on the B Cell.
Dr. Barone's publications by top research areas
Dr. Barone's grants focused on Sjogren's Syndrome.
Dr. Barone's grants
Dr. Laura K. Aguilar
The Chief Medical Officer has 13 publications and one grant.
Many of Dr. Aguilar's publications involved valaciclovir, and she wrote 13 of these papers with Dr. Aguilar-Cordova.
Dr. Aguilar's publications by top research area and category
Dr. Aguilar's grant focused on immuno-oncology for pancreatic cancer.
Dr. Aguilar's grant
Research across all of these databases was conducted quickly and efficiently using ResoluteAI’s Foundation. To talk to a real person about how Foundation can help you, please email us at info@resolute.ai or drop us a line using the link below.